Needham & Company
-
Needham & Company Maintains a 'Hold' on Sagent Pharmaceuticals (SGNT); Results On the Short Side of Expectations
-
Needham & Company Maintains a 'Hold' on Sagent Pharmaceuticals (SGNT); Impressive Q4, But Shares Fairly Valued
-
Needham & Company Downgrades Sagent Pharmaceuticals (SGNT) to Hold; Valuation Call
-
Needham & Company Starts Sagent Pharmaceuticals (SGNT) at Buy; New Kid On The Generic Block Should More Than Just Get By
-
Sagent Pharmaceuticals (SGNT) Files $100M IPO

